Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05138614 · ClinicalTrials.gov registry record · NA
Supporting Treatment Access and Recovery in COD
A NA study of Opioid Use Disorder and Mental Health Disorder, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 5
- Study locations
NCT05138614: Recruiting NA study of Opioid Use Disorder and Mental Health Disorder, sponsored by University of Massachusetts, Worcester.
NCT05138614 is a NA study of Opioid Use Disorder and Mental Health Disorder that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 1,000 participants, below the 4,652-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (79% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05138614, a NA study of Opioid Use Disorder and Mental Health Disorder, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
This 4-year study will randomize 1,000 people with co-occurring opioid use and mental health disorders (COD) at medication for opioid use disorder (MOUD) clinics to evaluate the effectiveness of MISSION, a multi-component team approach, or its components with MOUD versus MOUD alone, as well as the incremental benefits of MISSION or its components for improving outcomes. We expect that individuals receiving MISSION or its parts + MOUD will show greater improvement over MOUD alone on: engagement, substance use, and mental health.
Primary Outcome
Measured by total days in treatment
Conditions Studied
Interventions
- OTHER Medication for Opioid Use Disorder
- BEHAVIORAL MISSION Critical Time Intervention
- BEHAVIORAL MISSION Peer Support
- BEHAVIORAL MISSION Dual Recovery Therapy
Study Locations (5)
Massachusetts
- Behavioral Health Network - Holyoke
- Behavioral Health Network - Orange
- Behavioral Health Network - Springfield
- UMass Chan Road to Care Clinic - Worcester
- SaVida Health - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-03-11 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05138614 shows while recruiting
NCT05138614 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 4,652-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Medication for Opioid Use Disorder is the first listed.
NCT05138614 lists 5 locations in 1 state (Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05138614 about?
NCT05138614 is a clinical study titled "Supporting Treatment Access and Recovery in COD". This 4-year study will randomize 1,000 people with co-occurring opioid use and mental health disorders (COD) at medication for opioid use disorder (MOUD) clinics to evaluate the effectiveness of MISSION, a multi-component team approach, or its components with MOUD versus MOUD alone, as well as the i...
What is the current status of trial NCT05138614?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-03-11. Estimated completion is 2026-08-31.
What conditions does trial NCT05138614 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Mental Health Disorder.
What interventions are being tested in trial NCT05138614?
The interventions under investigation include: Medication for Opioid Use Disorder (OTHER), MISSION Critical Time Intervention (BEHAVIORAL), MISSION Peer Support (BEHAVIORAL), MISSION Dual Recovery Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05138614?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05138614 being conducted?
This trial has 5 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05138614's enrollment target sits among peer trials
1,000 18th of 257 higher than 239 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI